Clinical trial / 2008
Purple sweet potato drink lowered liver enzyme levels in men with borderline hepatitis.
Thirty-eight healthy Japanese men with elevated liver enzymes completed an 8-week trial receiving either two daily bottles of purple sweet potato beverage or placebo. The beverage group experienced significant reductions in serum gamma-glutamyl transferase, including differences of -14.1 IU/l (95% CI, -25.4 to -2.7) at week 2, -26.7 IU/l (95% CI, -47.6 to -5.7) at week 6, and -27.9 IU/l (95% CI, -49.9 to -5.9) at week 8. Interactions between group and time were also observed for AST and ALT.
- Study type
- Randomized double-blind placebo-controlled trial
- Who was studied
- 38 Japanese men (aged 30-54) with borderline hepatitis
- What was measured
- Serum hepatic biomarkers (GGT, AST, ALT)
THE PAPER
Intake of purple sweet potato beverage affects on serum hepatic biomarker levels of healthy adult men with borderline hepatitis.
Suda I, Ishikawa F, Hatakeyama M, Miyawaki M, Kudo T, Hirano K, Ito A, Yamakawa O, Horiuchi S. Eur J Clin Nutr, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.